Global Information
회사소개 | 문의 | 비교리스트

세계의 보균자 색출 시장 예측(-2024년) : 확대 보균자 색출(사전설계형, 맞춤형), 표적질환 보균자 색출

Carrier Screening Market by Product and Service, Type (Expanded Carrier (Predesigned, Customized), Targeted Disease Carrier), Medical Condition (Pulmonary, Hematological), Technology (Sequencing, PCR), End User, Region - Global Forecast to 2024

리서치사 MarketsandMarkets
발행일 2019년 11월 상품 코드 916831
페이지 정보 영문 149 Pages
가격
US $ 4,950 ₩ 5,930,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 7,966,000 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 9,763,000 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 11,980,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 보균자 색출 시장 예측(-2024년) : 확대 보균자 색출(사전설계형, 맞춤형), 표적질환 보균자 색출 Carrier Screening Market by Product and Service, Type (Expanded Carrier (Predesigned, Customized), Targeted Disease Carrier), Medical Condition (Pulmonary, Hematological), Technology (Sequencing, PCR), End User, Region - Global Forecast to 2024
발행일 : 2019년 11월 페이지 정보 : 영문 149 Pages

세계의 보균자 색출 시장은 예측기간 중 17.5%의 연평균 성장률(CAGR)로 추정되며, 2019년 18억 달러에서 2024년에는 40억 달러 규모로 성장할 것으로 예측됩니다. 질병의 조기 발견과 예방에 대한 초점 확대, 염색체 이상의 고위험성, 기술 발전 등의 요인이 시장 성장을 촉진하고 있습니다.

세계의 보균자 색출(Carrier Screening) 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 대한 각종 영향요인 및 시장 기회 분석, 제품 및 서비스·종류·질환·기술·최종사용자·지역/주요 국가별 동향, 시장 규모 추정과 예측, 경쟁 상황, 주요 기업 개요 등을 정리했습니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 주요 조사 결과

제5장 시장 개요

  • 서론
  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 과제

제6장 보균자 색출 시장 분석과 예측 : 제품 및 서비스별

  • 서론
  • 서비스
  • 제품

제7장 보균자 색출 시장 분석과 예측 : 종류별

  • 서론
  • 확대 보균자 색출
    • 사전설계형 패널 검사
    • 맞춤형 패널 검사
  • 표적질환 보균자 색출

제8장 보균자 색출 시장 분석과 예측 : 질환별

  • 서론
  • 폐질환
  • 혈액질환
  • 신경질환
  • 기타

제9장 보균자 색출 시장 분석과 예측 : 기술별

  • 서론
  • DNA 시퀀싱
  • 중합효소 연쇄 반응
  • 마이크로어레이
  • 기타

제10장 보균자 색출 시장 분석과 예측 : 최종사용자별

  • 서론
  • 병원
  • 표준실험실
  • 의사 사무실 및 진료실
  • 기타

제11장 보균자 색출 시장 분석과 예측 : 지역 및 주요 국가별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 기타 지역

제12장 경쟁 상황

  • 서론
  • 시장 순위
  • 경쟁 리더십 매핑
  • 경쟁 시나리오

제13장 기업 개요

  • INVITAE CORPORATION
  • FULGENT GENETICS
  • SEMA4
  • EUROFINS SCIENTIFIC
  • OPKO HEALTH
  • QUEST DIAGNOSTICS INCORPORATED
  • MYRIAD GENETICS
  • ILLUMINA
  • THERMO FISHER SCIENTIFIC
  • LUMINEX CORPORATION
  • NATERA
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • BGI
  • GENE BY GENE
  • PROGENITY
  • OTOGENETICS CORPORATION
  • CENTOGENE
  • PATHWAY GENOMICS
  • MEDGENOME
  • TRUE HEALTH

제14장 부록

KSM 19.11.25

LIST OF TABLES

  • TABLE 1: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 2: CARRIER SCREENING SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 3: NORTH AMERICA: CARRIER SCREENING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 4: EUROPE: CARRIER SCREENING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 5: CARRIER SCREENING PRODUCTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6: NORTH AMERICA: CARRIER SCREENING PRODUCTS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 7: EUROPE: CARRIER SCREENING PRODUCTS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 8: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 9: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 10: EXPANDED CARRIER SCREENING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: NORTH AMERICA: EXPANDED CARRIER SCREENING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 12: EUROPE: EXPANDED CARRIER SCREENING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 13: PREDESIGNED PANEL TESTING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14: NORTH AMERICA: PREDESIGNED PANEL TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 15: EUROPE: PREDESIGNED PANEL TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 16: CUSTOMIZED PANEL TESTING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17: NORTH AMERICA: CUSTOMIZED PANEL TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 18: EUROPE: CUSTOMIZED PANEL TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 19: TARGETED DISEASE CARRIER SCREENING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: NORTH AMERICA: TARGETED DISEASE CARRIER SCREENING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 21: EUROPE: TARGETED DISEASE CARRIER SCREENING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 22: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 23: LIVE BIRTH INCIDENCE OF CYSTIC FIBROSIS
  • TABLE 24: CARRIER SCREENING PRODUCTS/SERVICES FOR CYSTIC FIBROSIS
  • TABLE 25: CARRIER SCREENING MARKET FOR PULMONARY CONDITIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26: NORTH AMERICA: CARRIER SCREENING MARKET FOR PULMONARY CONDITIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 27: EUROPE: CARRIER SCREENING MARKET FOR PULMONARY CONDITIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 28: CARRIER SCREENING MARKET FOR HEMATOLOGICAL CONDITIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 29: NORTH AMERICA: CARRIER SCREENING MARKET FOR HEMATOLOGICAL CONDITIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 30: EUROPE: CARRIER SCREENING MARKET FOR HEMATOLOGICAL CONDITIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 31: GLOBAL PREVALENCE OF NEUROLOGICAL CONDITIONS
  • TABLE 32: CARRIER SCREENING PRODUCTS/SERVICES FOR NEUROLOGICAL CONDITIONS
  • TABLE 33: CARRIER SCREENING MARKET FOR NEUROLOGICAL CONDITIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 34: NORTH AMERICA: CARRIER SCREENING MARKET FOR NEUROLOGICAL CONDITIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 35: EUROPE: CARRIER SCREENING MARKET FOR NEUROLOGICAL CONDITIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 36: CARRIER SCREENING MARKET FOR OTHER MEDICAL CONDITIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 37: NORTH AMERICA: CARRIER SCREENING MARKET FOR OTHER MEDICAL CONDITIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 38: EUROPE: CARRIER SCREENING MARKET FOR OTHER MEDICAL CONDITIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 39: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 40: SEQUENCING TECHNOLOGIES USED BY MARKET PLAYERS
  • TABLE 41: CARRIER SCREENING MARKET FOR DNA SEQUENCING, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 42: NORTH AMERICA: CARRIER SCREENING MARKET FOR DNA SEQUENCING, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 43: EUROPE: CARRIER SCREENING MARKET FOR DNA SEQUENCING, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 44: PCR TECHNOLOGIES USED BY MARKET PLAYERS
  • TABLE 45: CARRIER SCREENING MARKET FOR PCR, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 46: NORTH AMERICA: CARRIER SCREENING MARKET FOR PCR, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 47: EUROPE: CARRIER SCREENING MARKET FOR PCR, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 48: MICROARRAY TECHNOLOGIES USED BY MARKET PLAYERS
  • TABLE 49: CARRIER SCREENING MARKET FOR MICROARRAYS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 50: NORTH AMERICA: CARRIER SCREENING MARKET FOR MICROARRAYS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 51: EUROPE: CARRIER SCREENING MARKET FOR MICROARRAYS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 52: CARRIER SCREENING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 53: NORTH AMERICA: CARRIER SCREENING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 54: EUROPE: CARRIER SCREENING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 55: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 56: CARRIER SCREENING MARKET FOR HOSPITALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 57: NORTH AMERICA: CARRIER SCREENING MARKET FOR HOSPITALS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 58: EUROPE: CARRIER SCREENING MARKET FOR HOSPITALS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 59: CARRIER SCREENING MARKET FOR REFERENCE LABORATORIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 60: NORTH AMERICA: CARRIER SCREENING MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 61: EUROPE: CARRIER SCREENING MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 62: CARRIER SCREENING MARKET FOR PHYSICIAN OFFICES AND CLINICS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 63: NORTH AMERICA: CARRIER SCREENING MARKET FOR PHYSICIAN OFFICES AND CLINICS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 64: EUROPE: CARRIER SCREENING MARKET FOR PHYSICIAN OFFICES AND CLINICS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 65: CARRIER SCREENING MARKET FOR OTHER END USERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 66: NORTH AMERICA: CARRIER SCREENING MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 67: EUROPE: CARRIER SCREENING MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 68: CARRIER SCREENING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 69: NORTH AMERICA: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 70: NORTH AMERICA: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 71: NORTH AMERICA: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 72: NORTH AMERICA: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 73: NORTH AMERICA: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 74: NORTH AMERICA: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 75: NORTH AMERICA: CARRIER SCREENING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 76: US: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 77: US: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 78: US: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 79: US: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 80: US: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 81: US: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 82: CANADA: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 83: CANADA: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 84: CANADA: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 85: CANADA: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 86: CANADA: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 87: CANADA: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 88: EUROPE: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 89: EUROPE: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 90: EUROPE: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 91: EUROPE: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 92: EUROPE: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 93: EUROPE: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 94: EUROPE: CARRIER SCREENING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 95: GERMANY: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 96: GERMANY: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 97: GERMANY: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 98: GERMANY: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 99: GERMANY: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 100: GERMANY: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 101: UK: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 102: UK: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 103: UK: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 104: UK: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 105: UK: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 106: UK: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 107: FRANCE: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 108: FRANCE: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 109: FRANCE: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 110: FRANCE: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 111: FRANCE: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 112: FRANCE: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 113: ROE: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 114: ROE: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 115: ROE: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 116: ROE: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 117: ROE: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 118: ROE: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 119: ASIA PACIFIC: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 120: ASIA PACIFIC: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 121: ASIA PACIFIC: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 122: ASIA PACIFIC: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 123: ASIA PACIFIC: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 124: ASIA PACIFIC: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 125: ROW: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 126: ROW: CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 127: ROW: EXPANDED CARRIER SCREENING MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 128: ROW: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 129: ROW: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2017-2024 (USD MILLION)
  • TABLE 130: ROW: CARRIER SCREENING MARKET, BY END USER, 2017-2024 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARIES: CARRIER SCREENING MARKET
  • FIGURE 3: RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 4: MARKET SIZE ESTIMATION: CARRIER SCREENING MARKET
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: CARRIER SCREENING MARKET, BY TECHNOLOGY, 2018
  • FIGURE 7: CARRIER SCREENING MARKET, BY PRODUCT & SERVICE, 2018
  • FIGURE 8: CARRIER SCREENING MARKET, BY MEDICAL CONDITION, 2018
  • FIGURE 9: CARRIER SCREENING MARKET, BY END USER, 2018
  • FIGURE 10: GEOGRAPHICAL SNAPSHOT OF THE CARRIER SCREENING MARKET
  • FIGURE 11: RISING GLOBAL GENETIC DISEASE BURDEN AND INCREASING FOCUS ON EARLY CARRIER SCREENING ARE DRIVING THE CARRIER SCREENING MARKET
  • FIGURE 12: GERMANY DOMINATES THE EUROPEAN MARKET FOR CARRIER SCREENING
  • FIGURE 13: PULMONARY CONDITIONS ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2018
  • FIGURE 14: DNA SEQUENCING SEGMENT DOMINATES THE CARRIER SCREENING MARKET
  • FIGURE 15: HOSPITALS TO HOLD THE LARGEST MARKET SHARE DURING 2019-2024
  • FIGURE 16: CARRIES SCREENING MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17: CARRIER SCREENING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 18: NORTH AMERICA: CARRIER SCREENING MARKET SNAPSHOT
  • FIGURE 19: ASIA PACIFIC: CARRIER SCREENING MARKET SNAPSHOT
  • FIGURE 20: RANK OF COMPANIES IN THE CARRIER SCREENING MARKET, 2018
  • FIGURE 21: CARRIER SCREENING MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019
  • FIGURE 22: INVITAE: COMPANY SNAPSHOT (2018)
  • FIGURE 23: FULGENT GENETICS: COMPANY SNAPSHOT (2018)
  • FIGURE 24: EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2018)
  • FIGURE 25: OPKO HEALTH: COMPANY SNAPSHOT (2018)
  • FIGURE 26: QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2018)
  • FIGURE 27: MYRIAD GENETICS: COMPANY SNAPSHOT (2018)
  • FIGURE 28: ILLUMINA: COMPANY SNAPSHOT (2018)
  • FIGURE 29: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2018)
  • FIGURE 30: LUMINEX: COMPANY SNAPSHOT (2018)
  • FIGURE 31: NATERA: COMPANY SNAPSHOT (2018)
  • FIGURE 32: LABCORP: COMPANY SNAPSHOT (2018)

"Increasing emphasis on early disease detection and prevention is expected to drive the growth of the global carrier screening market."

The global carrier screening market size is expected to grow from USD 1.8 billion in 2019 to USD 4.0 billion by 2024, at a CAGR of 17.5% during the forecast period. Growth in the carrier screening market can primarily be attributed to factors such as increasing emphasis on early disease detection and prevention, the high risk of chromosomal abnormalities, and technological advancements in carrier screening, such as the introduction of expanded carrier screening panels. The increasing awareness of carrier screening is expected to provide a wide range of growth opportunities for players in the market.

"The expanded carrier screening segment is expected to grow at the highest CAGR during the forecast period."

On the basis of type, the carrier screening market is segmented into targeted disease screening and expanded carrier screening, which includes predesigned and customized carrier screening panel testing. The growth of this segment can be attributed to factors such as the increasing use of new high-throughput technologies such as sequencing & microarrays and recommendations for the use of expanded carrier screening.

"In 2018, the hospitals segment accounted for the largest share of the carrier screening market."

On the basis of end user, the carrier screening market is segmented into hospitals, physician offices and clinics, reference laboratories, and other end users (blood banks, donor banks, community clinic laboratories, and non-profit organizations). In 2018, hospitals formed the largest end-user segment in the carrier screening market. Generally, gynecologists suggest couples to undergo carrier screening tests before and after pregnancy. In such cases, it is observed that gynecologists give reference for genetic counselors, who generally practice at hospitals. As a result, the awareness about hospital-based carrier screening tests is higher among patients than those offered at reference laboratories or at physician offices and clinics. Also, hospitals offer flexibility to patients in terms of sample collection, scheduling specimen pickups, and rapid turnaround time to produce results.

"North America to grow at the highest CAGR during the forecast period."

North America is expected to grow at the highest rate during the forecast period, followed by Europe. This growth can be attributed to several factors, such as the presence of well-established healthcare systems in the US and Canada, wide access to advanced screening techniques (such as DNA sequencing), recommendations for carrier screening, high and growing demand for the early detection of genetic disorders among the population, availability of mass genetic testing programs, increasing number of awareness campaigns, and the high incidence of chromosomal disorders.

In-depth interviews were conducted with chief executive officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the carrier screening market.

  • By Respondent Type: Supply-side: 80%, Demand-side: 20%
  • By Designation: C-level Executives: 27%, Directors: 18%, and Others: 55%
  • By Region: North America: 50%, Europe: 20%, APAC: 15%, and RoW: 15%

The carrier screening market comprises major players such as Illumina (US), Natera (US), Fulgent Genetics (US), Sema4 (US), Invitae (US), and LabCorp (US). The study includes an in-depth competitive analysis of these key players in the market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

The market study covers the carrier screening market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on the product & service, medical conditions, technology, condition, type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall carrier screening market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, opportunities, and challenges.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
  • 1.4 YEARS COVERED FOR THE STUDY
  • 1.5 CURRENCY
  • 1.6 LIMITATIONS
  • 1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 2.2.2 PRIMARY RESEARCH VALIDATION
  • 2.3 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 CARRIER SCREENING MARKET OVERVIEW
  • 4.2 EUROPE: CARRIER SCREENING MARKET SHARE, BY TYPE AND COUNTRY (2019)
  • 4.3 CARRIER SCREENING MARKET, BY MEDICAL CONDITION
  • 4.4 CARRIER SCREENING MARKET, BY TECHNOLOGY (USD MILLION) (2019 VS 2024)
  • 4.5 CARRIER SCREENING MARKET, BY END USER (USD MILLION) (2019 VS 2024)

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing emphasis on early disease detection and prevention
      • 5.2.1.2 High risk of chromosomal abnormalities with advancing maternal age
      • 5.2.1.3 Technological advancements
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Increasing awareness of carrier screening
    • 5.2.3 CHALLENGES
      • 5.2.3.1 Lack of skilled professionals
      • 5.2.3.2 Lack of standard guidelines for carrier screening

6 CARRIER SCREENING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
  • 6.2 SERVICES
    • 6.2.1 RISING NUMBER OF ACCREDITED LABORATORIES IS THE MAJOR INDICATOR OF MARKET GROWTH
  • 6.3 PRODUCTS
    • 6.3.1 EXPANDING USE OF CARRIER SCREENING TESTS HAS DRIVEN GROWTH IN THE PRODUCTS MARKET

7 CARRIER SCREENING MARKET, BY TYPE

  • 7.1 INTRODUCTION
  • 7.2 EXPANDED CARRIER SCREENING
    • 7.2.1 PREDESIGNED PANEL TESTING
      • 7.2.1.1 Predesigned panel testing accounts for the largest market share
    • 7.2.2 CUSTOMIZED PANEL TESTING
      • 7.2.2.1 Customized panels allow for specific sets of conditions to be screened
  • 7.3 TARGETED DISEASE CARRIER SCREENING
    • 7.3.1 INTRODUCTION OF PANELS CAPABLE OF SIMULTANEOUSLY SCREENING MULTIPLE CONDITIONS HAS DRIVEN MARKET GROWTH

8 CARRIER SCREENING MARKET, BY MEDICAL CONDITION

  • 8.1 INTRODUCTION
  • 8.2 PULMONARY CONDITIONS
    • 8.2.1 INCREASING AWARENESS ABOUT CYSTIC FIBROSIS AND CUSTOMIZED SERVICES IS LIKELY TO BOOST MARKET GROWTH
  • 8.3 HEMATOLOGICAL CONDITIONS
    • 8.3.1 RISING PREVALENCE OF HEMATOLOGICAL DISORDERS HAS INCREASED THE USE OF EXPANDED CARRIER SCREENING PANELS
  • 8.4 NEUROLOGICAL CONDITIONS
    • 8.4.1 GROWING AWARENESS OF NEUROLOGICAL SCREENING AND PRESENCE OF TARGETED SCREENING PANELS WILL SUPPORT MARKET GROWTH
  • 8.5 OTHER MEDICAL CONDITIONS

9 CARRIER SCREENING MARKET, BY TECHNOLOGY

  • 9.1 INTRODUCTION
  • 9.2 DNA SEQUENCING
    • 9.2.1 INCREASING NEED TO DETECT MULTIPLE GENES SIMULTANEOUSLY IS DRIVING DEMAND FOR NGS
  • 9.3 POLYMERASE CHAIN REACTION
    • 9.3.1 RISING NUMBER OF CARRIER SCREENING TESTS FOR TARGETED CHROMOSOMAL CONDITIONS HAS INCREASED THE USE OF PCR
  • 9.4 MICROARRAYS
    • 9.4.1 CLINICAL VALIDITY OF MICROARRAYS IN CARRIER SCREENING HAS INCREASED THEIR USE IN REFERENCE LABORATORIES
  • 9.5 OTHER TECHNOLOGIES

10 CARRIER SCREENING MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS
    • 10.2.1 HOSPITALS FORM THE LARGEST END-USER SEGMENT IN THE CARRIER SCREENING MARKET
  • 10.3 REFERENCE LABORATORIES
    • 10.3.1 ADVANTAGES OFFERED BY REFERENCE LABORATORIES IN TERMS OF SERVICE COSTS AND TURNAROUND TIME WILL SUPPORT MARKET GROWTH
  • 10.4 PHYSICIAN OFFICES AND CLINICS
    • 10.4.1 A LARGE NUMBER OF PHYSICIAN OFFICES AND CLINICS ARE OUTSOURCING CARRIER SCREENING TESTING SERVICES
  • 10.5 OTHER END USERS

11 CARRIER SCREENING MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 US
      • 11.2.1.1 US was the largest market for carrier screening products and services globally in 2018
    • 11.2.2 CANADA
      • 11.2.2.1 Awareness programs, campaigns, and conferences are promoting carrier screening in Canada
  • 11.3 EUROPE
    • 11.3.1 GERMANY
      • 11.3.1.1 Rising prevalence of genetic disorders to support market growth in Germany
    • 11.3.2 UK
      • 11.3.2.1 High incidence of genetic abnormalities to drive the demand for preconception screening in the UK
    • 11.3.3 FRANCE
      • 11.3.3.1 Government initiatives focused on genomics research are expected to support the growth of the carrier screening market in France
    • 11.3.4 ROE
  • 11.4 ASIA PACIFIC
    • 11.4.1 INCREASING GOVERNMENT SUPPORT WILL AID THE GROWTH OF THIS MARKET
  • 11.5 ROW
    • 11.5.1 ROW ACCOUNTS FOR THE SMALLEST SHARE OF THE GLOBAL MARKET

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 MARKET RANKING ANALYSIS
  • 12.3 COMPETITIVE LEADERSHIP MAPPING (2019)
    • 12.3.1 VENDOR INCLUSION CRITERIA
    • 12.3.2 VISIONARY LEADERS
    • 12.3.3 INNOVATORS
    • 12.3.4 DYNAMIC DIFFERENTIATORS
    • 12.3.5 EMERGING COMPANIES
  • 12.4 COMPETITIVE SCENARIO
    • 12.4.1 KEY PRODUCT AND SERVICE LAUNCHES
    • 12.4.2 KEY ACQUISITIONS
    • 12.4.3 KEY PARTNERSHIPS AND COLLABORATIONS

13 COMPANY PROFILES

(Business Overview, Products/Services Offered, Recent Developments, and MnM View)*

  • 13.1 INVITAE CORPORATION
  • 13.2 FULGENT GENETICS
  • 13.3 SEMA4
  • 13.4 EUROFINS SCIENTIFIC
  • 13.5 OPKO HEALTH
  • 13.6 QUEST DIAGNOSTICS INCORPORATED
  • 13.7 MYRIAD GENETICS
  • 13.8 ILLUMINA
  • 13.9 THERMO FISHER SCIENTIFIC
  • 13.10 LUMINEX CORPORATION
  • 13.11 NATERA
  • 13.12 LABORATORY CORPORATION OF AMERICA HOLDINGS
  • 13.13 BGI
  • 13.14 GENE BY GENE
  • 13.15 PROGENITY
  • 13.16 OTOGENETICS CORPORATION
  • 13.17 CENTOGENE
  • 13.18 PATHWAY GENOMICS
  • 13.19 MEDGENOME
  • 13.20 TRUE HEALTH

Details on Business Overview, Products/Services Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 AVAILABLE CUSTOMIZATIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS
Back to Top
전화 문의
F A Q